'Beck anxiety inventory' diaporamas de présentation

Theories and Data: Measurable Changes in Body and Mind during SM

Theories and Data: Measurable Changes in Body and Mind during SM . Ellen Lee James Ambler Northern Illinois University . Goals and Overview. Academic views of SM Our data collection and results Theories Future directions Questions!. Bridge Academia and SM Share findings

939 views • 84 slides

Mental Health Screening in Schools

A Web-Based, RWJF Caring Across Communities Sponsored Seminar October 22, 2007 Joshua Kaufman, LCSW School Mental Health Services, Los Angeles Unified School District. Mental Health Screening in Schools . MH Screening in Schools. Screening as a public health approach Implementation

1.6k views • 41 slides

Executive Abilities in Individuals with Phenylketonuria

Executive Abilities in Individuals with Phenylketonuria. Desiree A. White, PhD . Research supported by National Institute of Child Health & Human Development and BioMarin Pharmaceutical. Consultation and speaker fees accepted from BioMarin Pharmaceutical and Merck Serono.

442 views • 29 slides

Effects of mode and mood on self-report by college students

345 views • 24 slides

Anxiety Disorders in Older People

Anxiety Disorders in Older People. George T. Grossberg, MD Samuel W. Fordyce Professor Director, Geriatric Psychiatry Saint Louis University School of Medicine. Disclosure. None for this presentation. How Common is Clinically Significant Anxiety in Older.

532 views • 15 slides

How to Improve Your Writing with many thanks to: James A. Burns

How to Improve Your Writing with many thanks to: James A. Burns University of Nebraska-Lincoln. Much of your college performance will be determined by the quality of your writing.

185 views • 12 slides

Libby Jamieson (R.M.N.)

Libby Jamieson (R.M.N.). MENTAL HEALTH PRACTITIONER P.C.M.H.T. CLINICAL AREA. Population approx 88,000 people High numbers of refugees / asylum seekers High unemployment High incidence of crime High incidence of drug / alcohol misuse.

202 views • 10 slides

Mean Responses on PGI-Improvement Primary Endpoint at Week 12

Duloxetine. Placebo. Mean Responses on PGI-Improvement Primary Endpoint at Week 12. Very much better 1. Much better 2. ***. ***. ***. ***. A little better 3. No change 4. 2. 4. 8. 12. A little worse 5. Week of Study. Much worse 6.

117 views • 3 slides